These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 107314)

  • 1. Development of antibodies to meningococcal protein and lipopolysaccharide serotype antigens in healthy-carriers.
    Jones DM; Eldridge J
    J Med Microbiol; 1979 Feb; 12(1):107-11. PubMed ID: 107314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the level of antibodies to purified meningococcal antigens].
    Kuznetsova EM; Borisenko IuV; Tsvetkova NV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Jan; (1):65-8. PubMed ID: 3129887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis.
    Skevakis L; Frasch CE; Zahradnik JM; Dolin R
    J Infect Dis; 1984 Mar; 149(3):387-96. PubMed ID: 6425422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningococci.
    Sippel JE
    Crit Rev Microbiol; 1981; 8(3):267-302. PubMed ID: 6781818
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of protein serotype antigens in protection against disease due to Neisseria meningitidis.
    Frasch CE
    J Infect Dis; 1977 Aug; 136 Suppl():S84-90. PubMed ID: 408436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens.
    Braun JM; Beuth J; Blackwell CC; Giersen S; Higgins PG; Tzanakaki G; Unverhau H; Weir DM
    Vaccine; 2004 Feb; 22(7):898-908. PubMed ID: 15040943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal vaccines in prevention and control of meningitis.
    Saxena SN; Rawal IJ; Tripathi KK; Gupta P
    Indian Pediatr; 1985 Jun; 22(6):453-65. PubMed ID: 3938978
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cross-reacting intraspecies antigens of Neisseria meningitidis. II. The dynamics of antimeningococcal antibodies to cross-reacting antigens in different forms of meningococcal infection].
    Martynov IuV; Gracheva AM; Samsonova IM; Mol'kova LSh; Petina GK
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):60-5. PubMed ID: 6084377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serologic groups and types of meningococci].
    Demina AA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Jan; (1):11-7. PubMed ID: 6769266
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence of serum antibodies to Neisseria gonorrhoeae before gonococcal infection.
    Hicks CB; Boslego JW; Brandt B
    J Infect Dis; 1987 Jun; 155(6):1276-81. PubMed ID: 2883240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers.
    Arakere G; Frasch CE
    Infect Immun; 1991 Dec; 59(12):4349-56. PubMed ID: 1937795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human antibody response to the 70-Kd common neisserial antigen in patients and carriers of meningococci or non-pathogenic Neisseria.
    Aoun L; Lavitola A; Aubert G; Prère MF; Cremieux AC; Martin PM
    Ann Inst Pasteur Microbiol; 1988; 139(2):203-12. PubMed ID: 3136782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibodies to meningococcal lipopolysaccharide in different forms of meningococcal infection].
    Martynov IuV; Gracheva AM; Vengerov IuIa; Samsonova IM; Mol'kova LSh
    Zh Mikrobiol Epidemiol Immunobiol; 1989 May; (5):55-60. PubMed ID: 2506719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of meningococcal meningitis with meningococcal vaccines.
    Artenstein MS
    Yale J Biol Med; 1975 Jul; 48(3):197-200. PubMed ID: 808913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Specific antibody response in carriers of N. meningitidis].
    Tomásik E; Kuzemenská P
    Cesk Epidemiol Mikrobiol Imunol; 1989 Jul; 38(4):221-7. PubMed ID: 2507173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease.
    Litt DJ; Savino S; Beddek A; Comanducci M; Sandiford C; Stevens J; Levin M; Ison C; Pizza M; Rappuoli R; Kroll JS
    J Infect Dis; 2004 Oct; 190(8):1488-97. PubMed ID: 15378443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of immunity to serogroup B meningococci during carriage of Neisseria meningitidis in a cohort of university students.
    Jordens JZ; Williams JN; Jones GR; Christodoulides M; Heckels JE
    Infect Immun; 2004 Nov; 72(11):6503-10. PubMed ID: 15501781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of natural immunity to Neisseria meningitidis.
    Pollard AJ; Frasch C
    Vaccine; 2001 Jan; 19(11-12):1327-46. PubMed ID: 11163654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibody response in subjects with meningococal disease and in healthy carriers of Neisseria meningitidis].
    Natoli D; Tringali G; Puma G; Castellini S; Chiarini A
    G Batteriol Virol Immunol; 1976; 69(1-6):64-70. PubMed ID: 828887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.
    Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P
    Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.